November 13, 2006 February 28, 2020 Subjects : Report of Operating Performance for the Year 2019 Attention : President of the Stock Exchange of Thailand The Consolidated net profit of Eastern
15 May 2020 Subject : Management Discussion and Analysis for the First quarter of 2020 (Ending 31 March 2020) To : Managing Director The Stock Exchange of Thailand Getabec Public Company Limited
DEMCO 012 operating result Q 1-63 E DEMCO Public Company Limited No. Demco AC002/2020 May 18, 2020 Subject : The company’s operating result for the quarter 1/2020 To : The president, The Stock
T.K.S. TECHNOLOGIES 11 August 2020 Re: Management Discussion and Analysis for Quarter 2/2020 To: President The Stock Exchange of Thailand T.K.S. Technologies Public Company Limited (“TKS”) and its
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Analysis Report of the Financial Positions and Result of Business Operations. To : President of The Stock Exchange of Thailand The Explanation and Analysis Report of the Financial Positions and Result of
(Translation) UAC.CS/016/2019 November 7, 2019 Subject: Explanation of the operating results for the third quarter period ended September 30, 2019 To: President The Stock Exchange of Thailand
[COMPANY NAME] Ref.: EFORL IR 036/2019 November 14, 2019 Subject: Management Discussion and Analysis Quarter 3 Ending 30 September 2019 To President The Stock Exchange of Thailand 1. Overview
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
แบบแสดงรายการข้อมูลสำหรับการเสนอขายหลักทรัพย์ (แบบ 69-1) 1 No. WHAUP-CS021/2018 August 10, 2018 Attention: Managing Director – Stock Exchange of Thailand Subject: Report of Financial Results for the